ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Medtech giant Abbott is buying New Brighton-based Cardiovascular Systems Inc. for $890 million, expanding its portfolio in treating artery disease. Cardiovascular Systems (CSI) specializes in ...
An atherectomy is a minimally invasive procedure to remove plaque buildup from an artery (blood vessel). Removing this plaque allows blood to flow more freely through the artery. An atherectomy treats ...
Please provide your email address to receive an email when new articles are posted on . Orbital atherectomy was no better than balloon angioplasty for treatment of certain severely calcified coronary ...
Cardiovascular Systems Inc. (CSI) reported the submission by its partner Innova Vascular Inc. of U.S. FDA premarket notification for thrombectomy devices to treat peripheral vascular disease. Already ...
Introduction of Orbital Atherectomy in Canada Expands Treatment Options for Patients with Complex Coronary Artery Disease Dr. Kalra said, “Patients with calcific coronary artery disease can have poor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results